A Long-Term siRNA Strategy Regulates Fibronectin Overexpression and Improves Vascular Lesions in Retinas of Diabetic Rats
Penn collection
Degree type
Discipline
Subject
Basement Membrane
Blood Glucose
Body Weight
Capillaries
Diabetic Retinopathy
Fibronectins
Hemoglobin A
Glycosylated
Intravitreal Injections
Male
Pericytes
RNA
Small Interfering
Rats
Sprague-Dawley
Retina
Time Factors
Animal Diseases
Endocrinology, Diabetes, and Metabolism
Eye Diseases
Genetics and Genomics
Funder
Grant number
License
Copyright date
Distributor
Related resources
Author
Contributor
Abstract
Purpose: A sustained gene modulatory strategy is necessary for regulating abnormal gene expression in diabetic retinopathy, a long-term complication. We investigated the efficacy of a small interference RNA (siRNA) strategy in mediating the long-term downregulatory effect of fibronectin (FN) overexpression in vivo. Methods: Streptozotocin-induced diabetic rats were intravitreally injected with 3 µM of FN-siRNA at six week intervals over a period of 4.5 months. Retinal FN protein expression, vascular basement membrane (BM) thickness, and retinal vascular cell loss were assessed by western blot, electron microscopy, and retinal trypsin digest, respectively. Results: Retinal FN expression and BM thickness were significantly increased in diabetic rat retinas compared to those in non-diabetic control rats (188±14.2% of control versus 100±7.4% of control, p Conclusions: These findings suggest that BM thickening is an important target for preventing vascular cell loss in a diabetic retina, and that the siRNA approach could be useful for long-term gene modulation in diabetic retinopathy.